Form 8-K IRADIMED CORP For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Iradimed Corp. (IRMD) Tops Q2 EPS by 2c; Issues Confident Q3 Outlook, Boosts FY15 Guidance
July 30, 2015 9:16 AM EDTIradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $7.6 million versus the consensus estimate of $7.1 million.
Iradimed Corp. sees Q3 2015 EPS of $0.16-$0.17, versus the consensus of $0.13. Iradimed Corp. sees Q3 2015... More



